Summary
Updated Aug 30, 2026
Michael Andrew Holloway is Director of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). 3 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Michael Andrew Holloway has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Michael Andrew Holloway go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Michael Andrew Holloway's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
- Keith A. Meister - $533.93M of ILMN open-market activity in the last 12 months
- TPG GP A, LLC - $516.71M of LFST open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Paul R. Vigano - $371.84M of AVAH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael Andrew Holloway?
Michael Andrew Holloway is a corporate insider, tracked as Director of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Andrew Holloway submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Michael Andrew Holloway's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael Andrew Holloway and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial